Ms. Federer is an investor, board member, and a globally recognized leader in health technologies and women's health. She is the Managing Director for The Women's Health Fund, board member for USAWomen.org and chair of the Health of Women Investor Summit. She serves on the Yale Blavatnik Fund Advisory, Yale Institutional Review Board, the Duke Clinical Research Institute I3 Advisory Board, and the Board of Governors for Sidra Medicine. She is an external Senior Advisor to McKinsey, and is a seasoned public and private board member with experience across the U.S., Switzerland, Germany, Canada, and Italy. Previously, she was the Chief Digital Officer for one of the world’s largest life sciences companies, leading the enterprise-wide digital transformation for Bayer A.G. across the Pharmaceutical, Consumer Care, Crop Science, and Animal Health businesses. She was the first woman to hold this role in the pharma industry globally. Federer was a founding board member of Angelini Ventures, a Rome-based fund investing in biotech and digital health, and was previously a partner at an established Boston based VC. She was on the United Nations International Telecommunications Union m-powering development advisory board and the BHP Science and Innovation Advisory Council. She is recognized as an “Icon” by Rock Health, a Health Equity Champion, and one of the top 100 CDOs. Federer began her public health career at the Agency for Healthcare Research and Quality in the U.S. Department of Health and Human Services. She earned a Bachelor of Science from the George Washington University, and a Master of Public Health from Yale.